The Impact of Nonsteroidal Anti‐Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti‐PD‐1 Therapy in Advanced Melanoma

Anti–programmed cell death protein‐1 (anti‐PD‐1) therapy has greatly improved outcomes of patients with melanoma; however, many fail to respond. Although preclinical studies suggest a potentially synergistic relationship with anti‐PD‐1 therapy and certain concurrent medications, their clinical role...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Wang, Daniel Y., McQuade, Jennifer L., Rai, Rajat R., Park, John J., Zhao, Shilin, Ye, Fei, Beckermann, Kathryn E., Rubinstein, Samuel M., Johnpulle, Romany, Long, Georgina V., Carlino, Matteo S., Menzies, Alexander M., Davies, Michael A., Johnson, Douglas B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2019
Schlagworte:
Brief Communications
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066699/
https://ncbi.nlm.nih.gov/pubmed/32162820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0518
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge